Open AccessUncommon presentation of morphea related to interferon beta in a patient with concomitant multiple sclerosis and chronic hepatitis C: A case report
Author(s) -
Gupta Mrinal,
Yamauchi Paul S.,
Bagot Martine,
Szepietowski Jacek,
Bhatia Shibani,
Lotti Torello,
Goldust Mohamad
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2971
Subject(s) - medicine , concomitant , multiple sclerosis , interferon beta , morphea , chronic hepatitis , adverse effect , dermatology , interferon , hepatitis c , recombinant dna , immunology , virus , biochemistry , chemistry , lichen sclerosus , gene
Recombinant interferon beta‐1b is one of the treatment options of multiple sclerosis (MS). Insertional biologics that are used in the treatment of MS may lead to skin adverse effects, for example, morphea.